.png){kind=icon}
Study Details
8411-740 B5
Back To Current StudiesNon-Smoking Adults with a BMI of 30-39.9
Study Number
8411-740 B5Group
B5Gender
bothAge
18-55Location
Madison, WisconsinCompensation
$9,964Study Dates
Apr. 17 - May 25, 2021Additional Information
This is a research study for an investigational drug being developed for the treatment of obesity in adults. The purpose of this study is to evaluate the safety and tolerability (side effects) of single and multiple doses of the study drug at gradually increasing dose levels. The study will also measure how much of the study drug gets into the bloodstream, and how long it takes the body to get rid of it.
• Obese, otherwise healthy, Non-Smoking Adults, age 18-55. Females must be of non-childbearing potential
• BMI (body mass index) 30-39.9
• Join us for 31 nights, followed by 4 outpatient visits
• Compensation up to $9,964 may be provided for time and participation
Details
Call to schedule an appointment.
Group B5
Check-In: Apr 17
Check-Out: May 18
Outpatient Visits: May 19, 20, 22, 25
Study Number
8411-740 B5Group
B5Gender
bothAge
18-55Location
Madison, WisconsinCompensation
$9,964Study Dates
Apr. 17 - May 25, 2021Additional Information
This is a research study for an investigational drug being developed for the treatment of obesity in adults. The purpose of this study is to evaluate the safety and tolerability (side effects) of single and multiple doses of the study drug at gradually increasing dose levels. The study will also measure how much of the study drug gets into the bloodstream, and how long it takes the body to get rid of it.
• Obese, otherwise healthy, Non-Smoking Adults, age 18-55. Females must be of non-childbearing potential
• BMI (body mass index) 30-39.9
• Join us for 31 nights, followed by 4 outpatient visits
• Compensation up to $9,964 may be provided for time and participation
Details
Call to schedule an appointment.
Group B5
Check-In: Apr 17
Check-Out: May 18
Outpatient Visits: May 19, 20, 22, 25
